Cellular immunotherapy

Active cellular therapies usually involve the removal of immune cells from the blood or from a tumor. Those specific for the tumor are cultured and returned to the patient where they attack the tumor. Cell types that can be used in this way are natural killer cells, lymphokine-activated killer cells, cytotoxic T cells and dendritic cells. The only US-approved cell-based therapy is Dendreon's Provenge, for the treatment of prostate cancer.

  • Dendritic cell therapy

Related Conference of Cellular immunotherapy

November 21-22, 2019

World Conference on Vaccine and Immunology

MENA Plaza Hotel Albarsha | Dubai, UAE
November 21-22, 2019

14th International Conference on Allergy and Clinical Immunology

Courtyard by Marriot Bali Seminyak Resort | Bali, Indonesia
December 02-03, 2019

10th International Conference on Immunology & Immunogenetics

Park Inn by Radisson Hotel & Conference Centre London
June 28-30 2020

BIODIVERSITY 2020

June 28-30 2020

veternarymedicine-2020

June 28-30 2020

biopolymers-engg-2020

June 28-30 2020

BIOENERGY MEET 2020

June 28-30 2020

Immunology 2020

June 23-24, 2020

34th World Congress on Vaccines and Immunization

Osaka, Japan
September 14-15, 2020

35th World Congress on Immunology

Tokyo, Japan
Oct 12-13, 2020

International Conference on Vaccine and Vaccine Research

Manila, Philippines
October 14-15, 2020

13th International Conference on Allergy & Immunology

Zurich, Switzerland
2020-11-18

International Conference on Immunology & Immunotherapies

November 18-19, 2020 | Bangkok, Thailand
November 25-26, 2020

International Conference On European Immunology

London, UK
June 28-30 2020

worldnephrology 2021

June 28-30 2020

cancertherapy 2021

June 28-30 2020

rarediseases 2022

Cellular immunotherapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in